Antibody Analytics is a groundbreaking brand that specializes in transformative tools for the drug discovery process of immunotherapies. Their flagship product, IndEx-2, is an advanced inducible cell line development platform that revolutionizes the way we identify and target cancer-associated antigens. With IndEx-2, Antibody Analytics enables the selection of targeted immunotherapies with improved efficacy and enhanced safety profiles at the discovery stage.

By determining precise antigen density activation thresholds, they overcome the challenges of heterogeneity of expression in solid tumors and potential on-target, off-tumor toxicities. Their commitment to leveraging the immune system as a powerful strategy against cancer is backed by cutting-edge research and scientific expertise. They offer a comprehensive whitepaper that delves into the science behind IndEx-2, showcasing its key features and applications.

As advocates for cost-effective and efficient pre-clinical evaluation, Antibody Analytics aims to facilitate agile decision-making and pivot possibilities. For more information or to explore the capabilities of their IndEx-2 platform, you can schedule a meeting with their experienced scientific team. Stay ahead in the fight against cancer with Antibody Analytics